GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
A

Ascelia Pharma ACE.ST · SEK

Health Care · Nasdaq Stockholm · 🇸🇪 Sweden

Compare

0.53

-5.73%

Close of 9 Nov 2026, in SEK

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Ascelia Pharma annual report

Figures from our data supplier

We don't hold this company's report document. It publishes it on its own website.

Company website ↗

Five-year highlights

In SEK.

FY2025FY2024FY2023FY2022FY2021
Operating income−SEK 74.1m−SEK 67.8m−SEK 110.9m−SEK 147.0m−SEK 137.9m
Net income−SEK 76.3m−SEK 80.0m−SEK 109.3m−SEK 131.2m−SEK 125.9m
Free cash flow−SEK 72.3m−SEK 62.8m−SEK 253.6m−SEK 125.3m−SEK 116.6m
Total assetsSEK 111.9mSEK 140.9mSEK 87.1mSEK 218.6mSEK 333.5m
Shareholders' equitySEK 99.5mSEK 78.9mSEK 74.3mSEK 180.9mSEK 307.8m

Sources and methodology

Data on this tab
SEC EDGAR and our data supplier
Chart on the Overview
TradingView

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.